Journal of nuclear medicine : official publication, Society of Nuclear Medicine最新文献

筛选
英文 中文
A Call for Common Sense in the Use of Molecular Imaging. 呼吁在分子成像应用中建立常识。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270550
Ida Skarping, Thuy Tran, Rimma Axelsson, Renske Altena
{"title":"A Call for Common Sense in the Use of Molecular Imaging.","authors":"Ida Skarping, Thuy Tran, Rimma Axelsson, Renske Altena","doi":"10.2967/jnumed.125.270550","DOIUrl":"10.2967/jnumed.125.270550","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1500-1501"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12410286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential Association of PET-Derived Rest and Stress Myocardial Blood Flow with Cardiovascular Outcomes. pet衍生的休息和应激心肌血流量与心血管结局的差异关联。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.269457
Ahmed Sayed, Mahmoud Al Rifai, Mouaz Al-Mallah
{"title":"Differential Association of PET-Derived Rest and Stress Myocardial Blood Flow with Cardiovascular Outcomes.","authors":"Ahmed Sayed, Mahmoud Al Rifai, Mouaz Al-Mallah","doi":"10.2967/jnumed.125.269457","DOIUrl":"10.2967/jnumed.125.269457","url":null,"abstract":"<p><p>Although there is strong evidence for the prognostic value of myocardial flow reserve (MFR), there are fewer data on the prognostic implications of its constituents: myocardial blood flow at rest (MBF<sub>rest</sub>) and stress (MBF<sub>stress</sub>). <b>Methods:</b> Consecutive patients undergoing <sup>82</sup>Rb PET imaging with regadenoson stress testing at a tertiary care center between August 2019 and August 2024 were included in this study. The 2 coprimary outcomes were a composite of death or heart failure (HF) hospitalization and a composite of myocardial infarction (MI) or late revascularization. Multivariable Andersen-Gill Cox models with robust variance estimators were used to incorporate recurrent events. Outcomes were modeled as a smooth function of MBF<sub>stress</sub> and MBF<sub>rest</sub>, with restricted cubic splines to allow nonlinearity. <b>Results:</b> The analysis included 8,131 consecutive patients (median age of 68 y; 46.1% were women; median follow-up of 520 d (interquartile range, 186-921 d), among whom 471 deaths, 828 HF hospitalizations, 164 MIs, and 429 late revascularizations occurred. After adjusting for the relevant covariates, an MFR of 2 achieved through a lower MBF<sub>rest</sub> was associated with a significantly lower incidence of death and HF hospitalization, whereas an MFR of 2 achieved through a greater MBF<sub>stress</sub> was associated with a significantly lower incidence of MI and late revascularization. Assessments of the partial χ<sup>2</sup> statistic, which measures the importance of predictors, similarly confirmed that MBF<sub>rest</sub> was more important for predicting death or HF hospitalization whereas MBF<sub>stress</sub> was more important for predicting MI or late revascularization. <b>Conclusion:</b> Measurements of absolute myocardial blood flow offer complementary prognostic value to MFR. A diminished MBF<sub>stress</sub> may signal a greater risk of future ischemic outcomes, whereas an elevated MBF<sub>rest</sub> may signal a greater risk of future death or HF hospitalization.</p>","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1406-1411"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144328199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate. 精准医学对肿瘤学的未来至关重要:Johannes Czernin和Ken Herrmann与Chris Behrenbruch讨论治疗学、成像和创新的紧迫性。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270966
Christian Behrenbruch, Ken Herrmann, Johannes Czernin
{"title":"Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate.","authors":"Christian Behrenbruch, Ken Herrmann, Johannes Czernin","doi":"10.2967/jnumed.125.270966","DOIUrl":"10.2967/jnumed.125.270966","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1319-1322"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Predictive Dosimetry Is Now Freely Available. 快速预测剂量法现在是免费的。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270536
Yung Hsiang Kao
{"title":"Rapid Predictive Dosimetry Is Now Freely Available.","authors":"Yung Hsiang Kao","doi":"10.2967/jnumed.125.270536","DOIUrl":"10.2967/jnumed.125.270536","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1499-1500"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct Prognostic Roles of 18F-FDG PET Metabolic Response Assessed After Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma. 18F-FDG - PET代谢反应在局部食管鳞状细胞癌诱导化疗或放化疗后的预后作用
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.269775
Yeong Hak Bang, Jong Hoon Kim, Yong-Hee Kim, Hyeong Ryul Kim, Jin-Sook Ryu, Yong-Il Kim, Joon Seon Song, Sung-Bae Kim, Sook Ryun Park
{"title":"Distinct Prognostic Roles of <sup>18</sup>F-FDG PET Metabolic Response Assessed After Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma.","authors":"Yeong Hak Bang, Jong Hoon Kim, Yong-Hee Kim, Hyeong Ryul Kim, Jin-Sook Ryu, Yong-Il Kim, Joon Seon Song, Sung-Bae Kim, Sook Ryun Park","doi":"10.2967/jnumed.125.269775","DOIUrl":"10.2967/jnumed.125.269775","url":null,"abstract":"<p><p>The prognostic significance of metabolic response by posttreatment <sup>18</sup>F-FDG PET in esophageal squamous cell carcinoma (ESCC) treated with chemoradiotherapy remains unclear, particularly regarding metabolic response after induction chemotherapy versus after chemoradiotherapy. This study aimed to evaluate and compare their prognostic impact. <b>Methods:</b> This retrospective study analyzed 604 patients with localized ESCC who received induction chemotherapy followed by chemoradiotherapy, with or without surgery, at Asan Medical Center between 2006 and 2018. Metabolic responses after induction chemotherapy (before chemoradiotherapy) and after chemoradiotherapy were evaluated using European Organisation for Research and Treatment of Cancer-based criteria adapted for prognostic assessment. <b>Results:</b> In patients treated with definitive chemoradiotherapy (bimodality therapy), metabolic response after both induction chemotherapy and chemoradiotherapy was significantly associated with progression-free survival (PFS) and overall survival (OS). Complete metabolic response after induction chemotherapy correlated with the longest survival (PFS, 58.9 mo; OS, 90.8 mo), whereas progressive metabolic disease predicted poor prognosis (PFS, 3.7 mo; OS, 7.0 mo; <i>P</i> < 0.001). A similar pattern was observed for postchemoradiotherapy metabolic response. In patients who underwent surgery (trimodality therapy), metabolic response after induction chemotherapy did not significantly impact survival. However, in patients for whom surgery was initially planned, it remained prognostic, suggesting its prognostic relevance in the preoperative setting. Postchemoradiotherapy metabolic response was a strong independent prognostic factor in both bimodality therapy and trimodal therapy. Patients with diffuse esophagitis after chemoradiotherapy had intermediate survival outcomes, among complete metabolic response and partial metabolic response groups, indicating a distinct prognostic pattern. <b>Conclusion:</b> Postchemoradiotherapy metabolic response is a strong prognostic marker in localized ESCC, supporting its use for risk stratification. Early metabolic response after induction chemotherapy may also inform treatment decisions, particularly in surgery-intended patients.</p>","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1352-1364"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals. 上述非临床剂量学研究支持某些PET放射性药物的首次人体研究。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270320
Donika Plyku, Hayoung Koo, Luke Park, August Hofling, Libero Marzella
{"title":"Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals.","authors":"Donika Plyku, Hayoung Koo, Luke Park, August Hofling, Libero Marzella","doi":"10.2967/jnumed.125.270320","DOIUrl":"10.2967/jnumed.125.270320","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1497"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining Nuclear Medicine: "Biodistribution" Should Be the Core Concept. 重新定义核医学:“生物分布”应该是核心概念。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270245
Celso Dario Ramos
{"title":"Redefining Nuclear Medicine: \"Biodistribution\" Should Be the Core Concept.","authors":"Celso Dario Ramos","doi":"10.2967/jnumed.125.270245","DOIUrl":"10.2967/jnumed.125.270245","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1498"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to "Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals". 回复“上述非临床剂量学研究以支持某些PET放射性药物的首次人体研究”。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.270467
Marianna Dakanali, Steven S Zigler, Sally W Schwarz, Michael L Nickels, Reiko Oyama, Henry F VanBrocklin, Peter J H Scott
{"title":"Reply to \"Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals\".","authors":"Marianna Dakanali, Steven S Zigler, Sally W Schwarz, Michael L Nickels, Reiko Oyama, Henry F VanBrocklin, Peter J H Scott","doi":"10.2967/jnumed.125.270467","DOIUrl":"10.2967/jnumed.125.270467","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1497-1498"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Influenza B Virus-Associated Cerebellitis Detected by 18F-FDG PET/CT Imaging. 18F-FDG PET/CT检测1例罕见乙型流感病毒相关小脑炎。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.125.269548
Hukui Sun, Dayan Cheng, Xiangde Du, Chengwei Sun, Jiahui Zhang
{"title":"A Rare Influenza B Virus-Associated Cerebellitis Detected by <sup>18</sup>F-FDG PET/CT Imaging.","authors":"Hukui Sun, Dayan Cheng, Xiangde Du, Chengwei Sun, Jiahui Zhang","doi":"10.2967/jnumed.125.269548","DOIUrl":"10.2967/jnumed.125.269548","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1494"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[68Ga]Ga-FAPI PET/CT Monitors Response to Receptor Activator of Nuclear Factor-κB Ligand Inhibitor in a Giant Cell Tumor of Bone: Correlation with Histopathology. [68Ga]Ga-FAPI PET/CT监测骨巨细胞瘤对核因子-κB配体抑制剂受体激活物的反应:与组织病理学的相关性。
IF 9.1
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-09-02 DOI: 10.2967/jnumed.124.269432
Wenjie Zhang, Wenqing Yao, Guohua Shen
{"title":"[<sup>68</sup>Ga]Ga-FAPI PET/CT Monitors Response to Receptor Activator of Nuclear Factor-κB Ligand Inhibitor in a Giant Cell Tumor of Bone: Correlation with Histopathology.","authors":"Wenjie Zhang, Wenqing Yao, Guohua Shen","doi":"10.2967/jnumed.124.269432","DOIUrl":"10.2967/jnumed.124.269432","url":null,"abstract":"","PeriodicalId":94099,"journal":{"name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","volume":" ","pages":"1493"},"PeriodicalIF":9.1,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144083014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信